香港股市 已收市

中康控股 (2361.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
5.360-0.020 (-0.37%)
收市:03:57PM HKT

中康控股

Room 1111
No. 5 Wangjiang Second Street Huangge Town Nansha District
Guangzhou
China

https://ir.sinohealth.cn

版塊Healthcare
行業Health Information Services
全職員工759

高階主管

名稱頭銜支付行使價出生年份
Mr. Yushu WuChairman & CEO1.02M1976
Ms. Lifang WangCOO & Executive Director979.54k1975
Ms. Xuhui YiChief Financial Officer1973
Mr. Keke TangChief Technology Officer1987
Mr. Caihua SuChief Data Officer & VP1975
Ms. Xiao Zhang A.C.I.S., A.C.S.Joint Company Secretary1989
Mr. Chuan WanJoint Company Secretary1987
截止 2022年12月31日為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

Sinohealth Holdings Limited provides healthcare insight solutions for sales and marketing needs of medical product manufacturer clients in Mainland China and internationally. The company operates through four segments: Smart Retail Cloud, Smart Decision Cloud, Smart Health Management Cloud, and Smart Medical Cloud. It engages in the research and development and provision of data insight solutions, data-driven publications and events, and software as a service (SaaS) product; research and development and the operation of Smart Medical Cloud under the business line of SaaS products; management of marketing and promotion services of innovative medicine; operation of SaaS products; provision of internet information and internet data center services; and engages in foreign-related market research business. The company also offers precision marketing solutions; and consulting and marketing services. It serves various fields, such as pharmaceutical industry, retail pharmacies, and physical examination and hospitals. The company was founded in 2007 and is headquartered in Guangzhou, China.

公司管治

截至 無 止,中康控股 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。